Carregant...

Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential

Possibly through their actions upon glia, peroxisome proliferator-activated receptor agonists (PPAR) have been shown to alter the abuse potential of addictive drugs in several preclinical models. The current study extends this research into the human laboratory as the first clinical study into the e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmacol Biochem Behav
Autors principals: Jones, Jermaine D., Comer, Sandra D., Metz, Verena E., Manubay, Jeanne M., Mogali, Shanthi, Ciccocioppo, Roberto, Martinez, Suky, Mumtaz, Mudassir, Bisaga, Adam
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5959043/
https://ncbi.nlm.nih.gov/pubmed/29020601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbb.2017.10.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!